-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Inovio Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Inovio Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$27.3M, a 23.1% increase year-over-year.
- Inovio Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$119M, a 30.8% increase year-over-year.
- Inovio Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$144M, a 46.2% increase from 2022.
- Inovio Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$268M, a 11.2% increase from 2021.
- Inovio Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$301M, a 143% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)